Overview

Efficacy and Safety of Venetoclax Combined With BEAM Pretreatment in Autologous Transplantation for DLBCL

Status:
Not yet recruiting
Trial end date:
2025-11-30
Target enrollment:
Participant gender:
Summary
This single-center, randomized clinical study will evaluate the efficacy and safety of Venetoclax combined with BEAM Pretreatment Regimen in ASCT treatment of DLBCL patients.
Phase:
N/A
Details
Lead Sponsor:
Ruijin Hospital
Treatments:
Carmustine
Cytarabine
Etoposide
Melphalan
Venetoclax